Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
This development will position the company at the forefront of anti- malaria API production globally and is expected to drive substantial growth and profitability
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
The emergence of new infections in India is a growing concern
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives
The clinical trial will be conducted at 19 sites with 10,335 participants across India
Subscribe To Our Newsletter & Stay Updated
